A series of 5-thiocarbamate oxazolidinones was prepared and tested for in vitro and in vivo antibacterial activities. The results of in vitro antibacterial activity indicated that the 5-thiocarbamate group was a suitable substituent for the activity by the 5-moderate hydrophilicity. The compounds within a favorable log P value range were found to have potent in vitro antibacterial activity against gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Compounds 3a and 4h were superior to linezolid in both in vitro and in vivo potency and were considered to be hopeful compounds. We also discuss the pharmacokinetic properties of several compounds in mice.
Several antibiotics have been prescribed and found to be very effective on various infectious disorders. However, the appearance of multi-drug-resistant gram-positive bacteria, in particular, methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) is causing a serious menace. Moreover, the emergence of vancomycin-resistant MRSA can be anticipated in the foreseeable future. For the treatment of these intractable infections, a new anti-infectious agent is needed in clinical.
Oxazolidinone antibacterial agents 2) are a new class of synthetic antibacterial agents with activity against gram-positive bacteria. Their mode of action has been found to inhibit the protein synthesis in the initial stage. 3) Because of this unique mode of action, oxazolidinone is not cross-resistant with other types of antibiotics. Linezolid (1), 4) which was discovered by Pharmacia group, is well known as the first promising candidate of oxazolidinone and works effectively against numerous serious gram-positive human pathogens caused by MRSA and VRE.
In our preceding paper, 1) we described that 5-thiourea compounds 2a and 2b exhibited better in vitro antibacterial activities than linezolid. We also indicated that both the calculated log P value and the balance between 5-hydrophobic (or hydrophilic) substituent and hydrophilic (or hydrophobic) substituents on benzene ring would be important factors in the development of 5-thiocarbonyl oxazolidinone antibacterial agents. However, the in vivo activities of 2a and 2b were not sufficient. Thus, we converted the 5-thiourea group into 5-thiocarbamate oxazolidinones in order to find candidates with good in vitro and in vivo activities.
In this paper, we describe our SAR study on a series of 5-thiocarbamate oxazolidinones.
Chemistry 5-Thiocarbamate oxazolidinones were prepared as shown in Charts 2 and 3. Compounds 3a-e were synthesized from compound 5 1a) by treatment with the corresponding alcohols as shown in Chart 2.
(4Ј-Substituted)phenyl-5-thiocarbamate oxazolidinones 4 were prepared as shown in Chart 3 from key intermediates 7, which were easily derived from 6 by the usual method.
1b) The intermediates 7 were treated with carbon disulfide followed by ethyl chloroformate to give isothiocyanates 8. The thiocarbamate derivatives 4 were prepared from 8 by treatment with methanol. The physicochemical data of compounds 3 and 4 are shown in the experimental section.
Results and Discussion
All of the oxazolidinone derivatives were tested for antibacterial activity against both standard (Staphylococcus aureus SMITH) and clinically isolated strains [S. aureus HPC1360 (MRSA), S. aureus HPC428 (MRSA), Enterococcus faecium HPC1322 and E. casseliflavus HPC1310 (VRE)]. Their minimum inhibitory concentrations (MICs mg/ml) are shown in Tables 1 and 2 . The data of linezolid (1) and vancomycin were used as reference compounds.
We investigated the influence of side chain at 5-position on 5-thiocarbamate derivatives for antibacterial activities. The results of antibacterial activities are summarized in Table 1 . The activity of compound 3a showed 4 times stronger than that of linezolid (1) . However, the introduction of lengthened alkyl groups or cycloalkyl group at R 1 position decreased antibacterial activities. Thus, we focused O-methyl thiocarbamate group at 5-position, and synthesized some 4Ј-substituted oxazolidinones in this series. The antibacterial activities and hydrophobic parameter (calculated log P value) of 5-thiocarbamate oxazolidinones are summarized in Table 2 .
In our previous paper, 1b) we reported that the balance between 5-hydrophobic (or hydrophilic) substituent and hydrophilic (or hydrophobic) substituents on the benzene ring is one of the important factors in antibacterial activity in the 5-thiocarbonyl oxazolidinones. In this series, the prominent decrease of antibacterial activity was not observed. We assume that 5-O-methyl thiocarbamate group would be suitable for various substituents on the benzene ring because of its moderate hydrophilic substituent (paϭ0.30) compared with 5-thiourea (paϭϪ0.66) or 5-dithiocarbamate (paϭ0.88) groups.
1b)
We described earlier 1b) that the favorable calculated log P value for antibacterial activity in the case of 5-thiocarbonyl oxazolidinones was Ϫ1 to ϩ2. In this series, we also measured the calculated log P value.
5) The compounds within the favorable calculated log P value range provided stable antibacterial activities as we expected. Among them, compounds 4b (calculated log P value: 1.51), 4h (1.01), and 4i (0.73) showed stronger in vitro activities than linezolid (1) . On the contrary, compound 4e, whose calculated log P value was 3.10, showed weak activity. It was recently reported that the azole analogues at 4Ј-position have interesting levels of antibacterial activity in 5-acetamide oxazolidinones.
6) Compounds 4n and 4p also showed strong in vitro activities. The activities of compounds 4b, 4h, 4i, 4n and 4p were 8-16 times stronger than that of linezolid (1) .
In Vivo Activity The compounds that exhibited more potent in vitro antibacterial activity than linezolid (1) were actually tested for in vivo antibacterial activity against grampositive bacteria (S. aureus SMITH). The ED 50 (mg/kg) value of the oral route was determined based on the survival rates on day 7 after infection in mice. Among the oxazolidinones, compounds 3a and 4h exhibited higher in vivo activities than linezolid (1) as shown in Table 3 . The data showed 5-6 fold increases in oral activity compared with linezolid (1). Moreover, the thiocarbamate derivative 3a showed stronger in vivo activity than the corresponding thiourea derivative 2a. To learn the reason why the activity of 3a was stronger than that of 2a, we examined their pharmacokinetic profiles. (Table 4) It was found that the plasma concentration of compound 3a immediately disappeared. The plasma concentrations of S-oxide and S,S-dioxide, however, reached the maximum of 3.48 mg/ml at 1.0 h and 4.92 mg/ml at 6.0 h, respectively, after oral dosing of compound 3a. Both of them showed greatly higher serum concentrations compared to unchanged compound 3a, suggesting that the metabolites might be responsible for in vivo activity in the mouse systemic infectious model. On the other hand, compound 2a, which had 5-thiourea moiety, might be similarly metabolized to S-oxide or S,S-dioxide. But the in vitro activity of S-oxide was weak. In conclusion, 5-thiocarbamate oxazolidinones which had both a good balance of hydrophilic parameters (pa, pb) and favorable calculated log P value (Ϫ1 to ϩ2) were synthesized and their antibacterial activity were evaluated. Among them, compounds 3a and 4h showed good in vitro and in vivo activities compared with linezolid. These compounds are thus expected to be effective candidates for numerous grampositive infections.
Experimental
Melting points were measured with a Yanagimoto melting point apparatus and are uncorrected. Elemental analyses were measured with a Yanagimoto MT-5 elemental analysis apparatus, and were within Ϯ0.4% of calculated values.
1 H-NMR spectra were measured with a JEOL A-500 (500 MHz) or JEOL JNM-LA300 (300 MHz) spectrometer using tetramethylsilane as an internal standard. High-resolution mass spectra were measured on a JEOL DX-300 mass spectrometer. Specific optical rotations were measured on a JASCO DIP-370 polarimeter. Column chromatography was carried out with silica gel [Kieselgel 60 (Merck)]. TLC was conducted on 0.25 mm precoated silica gel plates (60F 254 , Merck). All extracted solvents were dried over Na 2 SO 4 and the solvent was evaporated in vacuo.
O-Methyl (S )-[[3-[3-Fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]thiocarbamate (3a)
To a solution of NaH (60% in oil, 0.53 g, 13.3 mmol) in MeOH (44 ml), a mixture of 5 1a) (4.41 g, 12.5 mmol) was added under ice cooling, followed by stirring at room temperature for 3 h. Then the reaction mixture was poured into ice water and adjusted to pH 7 with dilute hydochloric acid. The precipitates were collected by filtration and washed with water to afford 3a as pale brown crystals. The physicochemical data are listed in Tables 5 and 6 .
Compounds 3b-e were respectively prepared from 5 in a similar manner. The physicochemical data are listed in Tables 5 and 6 .
(S )-5-Aminomethyl-3-[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]oxazolidine-2-one (7k) A mixture of (R)-5-azidomethyl-3-[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]oxazolidine-2-one (11.2 g, 27.1 mmol), which was prepared from compound 6 by the usual method, 1b) triphenylphosphine (7.82 g, 29.8 mmol) and H 2 O (4.8 ml, 271 mmol) in tetrahydrofuran (THF) (170 ml) was heated at 40°C for 17 h. After cooling, the reaction mixture was diluted with water and dilute hydrochloric acid and extracted with AcOEt. The aqueous layer was made alkaline with aqueous NaOH and extracted with AcOEt. The extract was washed with water, dried and concentrated to afford 7k (4.55 g, 54%) as pale yellow amorphous. (1H, t, Jϭ9 Hz), 4.78-4.85 (1H, m), 6.96 (1H, t, Jϭ9 Hz) 
O-Methyl (S )-[[3-[3-Fluoro-4-(4-methyl-1-piperazinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]thiocarbamate (4k)
To a solution of NaH (60 wt% in oil, 0.18 g, 7.53 mmol) in MeOH (5 ml), a mixture of 8k (1.32 g, 3.77 mmol) in MeOH (5 ml) was added under ice cooling, followed by stirring at room temperature for 17 h. Then the reaction mixture was poured into ice water and adjusted to pH 7 with dilute hydochloric acid. The precipitates were collected by filtration and washed with water to afford 4k as colorless crystals. The physicochemical data are listed in Tables 7 and 8 .
Compounds 4 were respectively prepared from the corresponding 8 in a similar manner. The physicochemical data are listed in Tables 7 and 8 .
In Vitro Antibacterial Test These studies were conducted according to the method of the Japan Society of Chemotherapy.
8) The MICs (mg/ml) were determined by an agar dilution method with Muller-Hinton agar (MHA, Difco Laboratories, Detroit, Mich). Bacterial suspensions for inocula were prepared by diluting overnight cultures of organisms to give a final concentration of 10 6 CFU/ml, and one loopful (5 ml) of an inoculum, corresponding to about 5ϫ10 3 CFU per spot was inoculated on drug-containing agar plates. The plates were incubated for 18-24 h at 37°C. The MIC was defined as the lowest drug concentration that prevented visible growth of bacteria.
In Vivo Antibacterial Test Four week old male ICR mice (18-21 g body weight) were infected intraperitoneally with bacterial suspension. The bacterium used for infection was S. aureus Smith (3-7ϫ10 7 ). Following infection, graded doses of compounds were administered orally to mice in groups of 10 each. The ED 50 , including 95% confidence limits, was calculated by the probit method 9) from the survival rates on day 7 after infection. 
